Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 04, 2026
FTAI Aviation (FTAI) Pulls Back Roughly 9% Following Q2 Earnings Miss

FTAI Aviation (FTAI) Pulls Back Roughly 9% Following Q2 Earnings Miss

Key Takeaways

  • FTAI Aviation shares have pulled back roughly 9% over the past 30 days, retreating from approximately $248 to the $225 area, following a second-quarter earnings report that missed consensus EPS estimates despite record quarterly revenue.
  • The company reported Q2 2026 revenue of $953 million, up 40.9% year-over-year, while adjusted EPS of $1.13 came in below the $1.32 analyst consensus, triggering post-earnings selling pressure.
  • Insider buying by President David Moreno — who purchased approximately $498,000 worth of shares at an average price near $201 — helped stabilize sentiment and drove a sharp single-day rebound of over 9% in early August.
  • FTAI Power, the company's newly launched business converting CFM56 engines into aeroderivative turbines for data centers, secured a landmark $1.47 billion initial purchase order, reinforcing long-term growth visibility beyond core aviation markets.
  • Analyst consensus remains broadly bullish with a "Moderate Buy" to "Strong Buy" rating and price targets ranging from $290 to $600, though several firms trimmed targets following the earnings shortfall.
  • The stock trades below both its 50-day and 200-day moving averages, reflecting near-term technical weakness despite a fundamentally constructive long-term outlook.

Market Snapshot: Where FTAI Aviation Stands Now

FTAI Aviation stock enters August 2026 trading near $225 per share, sitting below its 50-day moving average of approximately $239 and its 200-day moving average near $253. The shares have endured a volatile stretch, bouncing between a 52-week high of $323.51 and a low of $128.32. With a market capitalization exceeding $21 billion and a beta of 1.51, FTAI exhibits above-average sensitivity to broader market swings, and the recent pullback reflects a combination of earnings disappointment and macro uncertainty tied to elevated jet fuel prices linked to geopolitical tensions. Institutional ownership remains exceptionally high at nearly 89%, underscoring deep conviction among professional investors despite recent turbulence.

Understanding FTAI Aviation's Business and Position

FTAI Aviation is a vertically integrated commercial aircraft engine maintenance, repair, and leasing company focused on the CFM56 and V2500 engine platforms — the most widely deployed narrow-body jet engines in global aviation, powering the Boeing 737NG and Airbus A320ceo families. The company operates through two core segments: Aerospace Products, which develops, manufactures, refurbishes, and sells engine modules and aftermarket components, and Aviation Leasing, which owns and manages a portfolio of aircraft and engines leased to airlines worldwide. FTAI's proprietary Module Factory approach and its joint venture producing PMA (Parts Manufacturer Approval) components enable cost-efficient engine lifecycle solutions for hundreds of small and medium-sized airline operators. In late 2025, the company launched FTAI Power, a platform dedicated to converting retired CFM56 engines into aeroderivative power turbines — a business that positions FTAI at the intersection of aviation aftermarket expertise and surging data center energy demand. With maintenance facilities across Montreal, Miami, Lisbon, Rome, and beyond, and a growing Strategic Capital Initiative that attracts third-party institutional investment into aircraft leasing, FTAI has built a scalable, asset-light ecosystem with multiple revenue streams. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Developments Driving the Stock

The most consequential event in the last 30 days was FTAI's Q2 2026 earnings release on July 29. While revenue surged 40.9% year-over-year to $953.09 million — a company record — adjusted EPS of $1.13 fell $0.19 short of the consensus estimate. The miss triggered a sharp sell-off that sent shares tumbling from the $210-$215 range down toward $197 before bargain hunting and a timely insider purchase reversed the slide. President David Moreno disclosed a purchase of 2,475 shares at an average price of approximately $201 on July 31, a roughly $498,000 vote of confidence that catalyzed a 9.3% single-day rally on August 3. On the operational front, FTAI announced strategic maintenance partnerships with EgyptAir in Cairo and GMF AeroAsia in Jakarta, expanding its engine service footprint eastward and adding capacity for its module restoration business. The company also disclosed that its J&F Power Systems joint venture with Jerry Group signed a master supply agreement and a $1.47 billion initial purchase order with a major U.S. hyperscaler for Mod-1 module deliveries through 2027. Meanwhile, BTIG lowered its price target from $400 to $350 (keeping a Buy rating), and Deutsche Bank trimmed its target to $290, while Jefferies, Barclays, RBC Capital, and Wolfe Research all maintained bullish ratings.

2026 Outlook and Key Areas to Monitor

Looking ahead, FTAI's trajectory hinges on several interconnected factors. The company has raised its 2026 module production target to 1,200 units, reflecting strong execution and growing customer adoption of its maintenance, repair, and exchange model. Aerospace Products EBITDA guidance of $10.5 billion-equivalent annualized run rate remains intact, while Aviation Leasing EBITDA was revised lower to $475 million as management accelerates the shift toward an asset-light structure. The FTAI Power segment represents the most significant upside catalyst: first aeroderivative deliveries are expected in Q4 2026, and the $1.47 billion order book provides concrete revenue visibility into 2027. Key risks include sustained elevation in jet fuel prices from geopolitical instability, potential delays in regulatory certifications for PMA parts, and credit market conditions that could affect the company's ability to raise third-party capital through its Strategic Capital Initiative vehicles. Investors should monitor upcoming quarterly filings for progress on module production rates, FTAI Power commercialization milestones, and any revisions to full-year adjusted free cash flow guidance currently targeted near $878 million. The dividend — recently raised to $0.50 per share — and Moody's credit rating upgrade to Ba1 signal management's confidence in the balance sheet, but execution across all three business lines will be essential to justify analyst price targets that imply significant upside from current levels. From what I see, the long-term setup remains constructive if the company delivers on its targets.

Using AI Tools to Track Complex Names

I've found Tickeron's AI Trading Bots useful when evaluating stocks like this one amid earnings volatility and shifting sector dynamics. The platform's algorithmic strategies can help surface data-driven perspectives on momentum and patterns that complement traditional fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FTAI

FTAI's RSI Indicator climbs out of oversold territory

The RSI Oscillator for FTAI moved out of oversold territory on July 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In of the 14 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where FTAI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on FTAI as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FTAI just turned positive on August 03, 2026. Looking at past instances where FTAI's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FTAI advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

FTAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

FTAI moved below its 50-day moving average on July 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FTAI crossed bearishly below the 50-day moving average on July 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FTAI entered a downward trend on August 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FTAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: FTAI's P/B Ratio (56.497) is slightly higher than the industry average of (10.104). P/E Ratio (48.463) is within average values for comparable stocks, (61.816). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.110). Dividend Yield (0.007) settles around the average of (0.016) among similar stocks. P/S Ratio (7.435) is also within normal values, averaging (31.588).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 38.6B. The market cap for tickers in the group ranges from 4.49 to 1.65T. SPCX holds the highest valuation in this group at 1.65T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 8%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 7%. DFNS experienced the highest price growth at 97%, while VWAV experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 67
Price Growth Rating: 61
SMR Rating: 79
Profit Risk Rating: 72
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
FTAI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a private equity fund

Industry AerospaceDefense

Profile
Details
Industry
Investment Managers
Address
405 West 13th Street
Phone
+1 332 239-7600
Employees
985
Web
https://www.ftaiaviation.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.